Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vik Meadows

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Hepatology (Baltimore, Md.)|January 12, 2021
Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and Microvesicular Steatosis in Mice Fed a Western DietLindsey Kennedy, Vik Meadows, Amelia Sybenga, et al.
Cells|May 14, 2022
The Effects of Taurocholic Acid on Biliary Damage and Liver Fibrosis Are Mediated by Calcitonin-Gene-Related Peptide SignalingRomina Mancinelli, Ludovica Ceci, Lindsey Kennedy, et al.
Cells|January 19, 2026
RETRACTED: Mancinelli et al. The Effects of Taurocholic Acid on Biliary Damage and Liver Fibrosis Are Mediated by Calcitonin-Gene-Related Peptide Signaling. <i>Cells</i> 2022, <i>11</i>, 1591Romina Mancinelli, Ludovica Ceci, Lindsey Kennedy, et al.
Hepatology (Baltimore, Md.)|November 7, 2021
Melatonin receptor 1A, but not 1B, knockout decreases biliary damage and liver fibrosis during cholestatic liver injuryNan Wu, Guido Carpino, Ludovica Ceci, et al.
Journal of Hepatology|August 20, 2022
Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processesLindsey Kennedy, Guido Carpino, Travis Owen, et al.
Hepatology (Baltimore, Md.)|October 23, 2025
Glutamine synthetase loss in β-catenin-mutant hepatocellular carcinoma promotes tumor burden through macrophage metabolic reprogrammingEvan R Delgado, Panari Patel, Junyan Tao, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 20, 2024
Effects of therapeutically approved individual bile acids on the development of metabolic dysfunction-associated steatohepatitis a low bile acid mouse modelRulaiha Taylor, Veronia Basaly, Bo Kong, et al.
The American Journal of Pathology|July 27, 2020
Knockout of the Tachykinin Receptor 1 in the Mdr2<sup>-/-</sup> (Abcb4<sup>-/-</sup>) Mouse Model of Primary Sclerosing Cholangitis Reduces Biliary Damage and Liver FibrosisLudovica Ceci, Heather Francis, Tianhao Zhou, et al.
Egastroenterology|October 2, 2025
Ursodeoxycholic acid acts as an ileal FXR agonist in male mice with hepatic deficiency of FXRZakiyah R Henry, Syeda Maliha, Veronia Basaly, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 21, 2022
Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitisVik Meadows, Corinn Marakovits, Burcin Ekser, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Hepatology (Baltimore, Md.)|January 12, 2021
Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and Microvesicular Steatosis in Mice Fed a Western DietLindsey Kennedy, Vik Meadows, Amelia Sybenga, et al.
Cells|May 14, 2022
The Effects of Taurocholic Acid on Biliary Damage and Liver Fibrosis Are Mediated by Calcitonin-Gene-Related Peptide SignalingRomina Mancinelli, Ludovica Ceci, Lindsey Kennedy, et al.
Cells|January 19, 2026
RETRACTED: Mancinelli et al. The Effects of Taurocholic Acid on Biliary Damage and Liver Fibrosis Are Mediated by Calcitonin-Gene-Related Peptide Signaling. <i>Cells</i> 2022, <i>11</i>, 1591Romina Mancinelli, Ludovica Ceci, Lindsey Kennedy, et al.
Hepatology (Baltimore, Md.)|November 7, 2021
Melatonin receptor 1A, but not 1B, knockout decreases biliary damage and liver fibrosis during cholestatic liver injuryNan Wu, Guido Carpino, Ludovica Ceci, et al.
Journal of Hepatology|August 20, 2022
Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processesLindsey Kennedy, Guido Carpino, Travis Owen, et al.
Hepatology (Baltimore, Md.)|October 23, 2025
Glutamine synthetase loss in β-catenin-mutant hepatocellular carcinoma promotes tumor burden through macrophage metabolic reprogrammingEvan R Delgado, Panari Patel, Junyan Tao, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 20, 2024
Effects of therapeutically approved individual bile acids on the development of metabolic dysfunction-associated steatohepatitis a low bile acid mouse modelRulaiha Taylor, Veronia Basaly, Bo Kong, et al.
The American Journal of Pathology|July 27, 2020
Knockout of the Tachykinin Receptor 1 in the Mdr2<sup>-/-</sup> (Abcb4<sup>-/-</sup>) Mouse Model of Primary Sclerosing Cholangitis Reduces Biliary Damage and Liver FibrosisLudovica Ceci, Heather Francis, Tianhao Zhou, et al.
Egastroenterology|October 2, 2025
Ursodeoxycholic acid acts as an ileal FXR agonist in male mice with hepatic deficiency of FXRZakiyah R Henry, Syeda Maliha, Veronia Basaly, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 21, 2022
Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitisVik Meadows, Corinn Marakovits, Burcin Ekser, et al.
Pageof 5